Comparative evaluation of the pharmacological activity of coniferous provitamin concentrate and Serenoa repens (Sabal serrulatum) extract using a model of testosterone-induced benign prostatic hyperplasia in rats
Introduction. Phytotherapy continues to play an important role in the treatment of patients with benign prostatic hyperplasia (BPH).
Aim. To evaluate the pharmacological activity of a complex of biologically active compounds isolated from the foliage of Picea abies L. and Pinus sylvestris L. (coniferous provitamin concentrate, CPC) in comparison with S. repens extract (Prostamol®Uno, Germany) using the testosterone-induced BPH model in rats.